{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:40:18Z","timestamp":1791333618455,"version":"4.3.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004543","name":"China Scholarship Council","doi-asserted-by":"publisher","award":["EK\\u00D6P-2025-434"],"award-info":[{"award-number":["EK\\u00D6P-2025-434"]}],"id":[{"id":"10.13039\/501100004543","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020027","name":"Dr. Rolf M. Schwiete Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020027","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012550","name":"Nemzeti Kutat\u00e1si, Fejleszt\u00e9si \u00e9s Innovaci\u00f3s Alap","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012550","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.ajo.2025.11.027","type":"journal-article","created":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T22:50:05Z","timestamp":1763765405000},"page":"405-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Outcomes of Penetrating Keratoplasty and Boston Type 1 Keratoprosthesis in Aniridia-Associated Keratopathy: A Systematic Review and Meta-Analysis"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9176-9442","authenticated-orcid":false,"given":"G\u00c1BOR","family":"T\u00d3TH","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHANHE","family":"LIU","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SHUAILIN","family":"LI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SZIL\u00c1RD","family":"V\u00c1NCSA","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00c1TY\u00c1S","family":"PACZK\u00d3","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TAM\u00c1S","family":"K\u00d3I","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P\u00c9TER","family":"HEGYI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00d3RA","family":"SZENTM\u00c1RY","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ajo.2025.11.027_bib0001","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/0039-6257(84)90184-X","article-title":"Aniridia: a review","volume":"28","author":"Nelson","year":"1984","journal-title":"Surv Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.027_bib0002","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1016\/j.survophthal.2021.02.011","article-title":"Congenital aniridia - a comprehensive review of clinical features and therapeutic approaches","volume":"66","author":"Landsend","year":"2021","journal-title":"Surv Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajo.2025.11.027_bib0003","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1038\/ejhg.2012.100","article-title":"Aniridia","volume":"20","author":"Hingorani","year":"2012","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/j.ajo.2025.11.027_bib0004","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1471-2156-6-27","article-title":"PAX mutations: genotype-phenotype correlations","volume":"6","author":"Tzoulaki","year":"2005","journal-title":"BMC Genet"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.027_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/ICO.0000000000001412","article-title":"Intermediate-term and long-term outcomes with the Boston type 1 keratoprosthesis in aniridia","volume":"37","author":"Shah","year":"2018","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.027_bib0006","article-title":"Long-term anatomical and functional survival of Boston type 1 keratoprosthesis in congenital aniridia","volume":"8","author":"Dyer","year":"2021","journal-title":"Front Med (Lausanne)"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.027_bib0007","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ajo.2014.05.009","article-title":"Outcomes following Boston type 1 keratoprosthesis implantation in aniridia Patients at the University of Montreal","volume":"158","author":"Hassanaly","year":"2014","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.027_bib0008","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1755-3768.2008.01293.x","article-title":"Long-term visual prognosis of corneal and ocular surface surgery in patients with congenital aniridia","volume":"86","author":"de la Paz","year":"2008","journal-title":"Acta Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.027_bib0009","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1097\/ICO.0000000000000830","article-title":"In situ corneal crosslinking for recurrent corneal melting following Boston type 1 keratoprosthesis","volume":"35","author":"T\u00f3th","year":"2016","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.027_bib0010","first-page":"372:n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"29","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2025.11.027_tboref0001","unstructured":"Higgins J.P.T., Thomas J., Chandler J., Cumpston M., Li T., Page M.J., et al. Cochrane Handbook for Systematic Reviews of Interventions Version 6.3. Cochrane; 2022. Accessed July 14, 2025."},{"key":"10.1016\/j.ajo.2025.11.027_bib0012","unstructured":"Critical-appraisal-tools \u2013 Critical appraisal tools. JBI. Accessed July 16, 2025. http:\/\/jbi.global\/critical-appraisal-tools"},{"key":"10.1016\/j.ajo.2025.11.027_bib0013","series-title":"Doing meta-analysis with R. A hands-on guide","author":"Harrer","year":"2021"},{"issue":"29","key":"10.1016\/j.ajo.2025.11.027_bib0014","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1002\/sim.4040","article-title":"Random effects meta-analysis of event outcome in the framework of the generalized linear mixed model with applications in sparse data","volume":"29","author":"Stijnen","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/j.ajo.2025.11.027_bib0015","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1471-2288-12-9","article-title":"Enhanced secondary analysis of survival data: reconstructing the data from published Kaplan-Meier survival curves","volume":"12","author":"Guyot","year":"2012","journal-title":"BMC Med Res Methodol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.027_bib0016","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.ajo.2007.04.036","article-title":"Outcomes of Boston keratoprosthesis in aniridia: a retrospective multicenter study","volume":"144","author":"Akpek","year":"2007","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.027_bib0017","first-page":"425","article-title":"Lateral tarsorrhaphy and disposable soft contact lenses in aniridia patients after penetrating keratoplasty","volume":"24","author":"Au","year":"1993","journal-title":"Ophthalmic Surg"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.027_bib0018","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ajo.2011.10.027","article-title":"Surgical and visual outcomes of the type i boston keratoprosthesis for the management of aniridic fibrosis syndrome in congenital aniridia","volume":"153","author":"Bakhtiari","year":"2012","journal-title":"Am J Ophthalmol"},{"issue":"19","key":"10.1016\/j.ajo.2025.11.027_bib0019","doi-asserted-by":"crossref","first-page":"6276","DOI":"10.3390\/jcm12196276","article-title":"Penetrating keratoplasty in congenital glaucoma","volume":"12","author":"Batu Oto","year":"2023","journal-title":"J Clin Med"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.027_bib0020","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/ICO.0b013e31818b8bfa","article-title":"Boston Type 1 Keratoprosthesis: the university of california davis experience","volume":"28","author":"Bradley","year":"2009","journal-title":"Cornea"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.027_bib0021","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.ophtha.2012.11.025","article-title":"Retention of the Boston keratoprosthesis type 1: multicenter study results","volume":"120","author":"Ciolino","year":"2013","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2025.11.027_bib0022","doi-asserted-by":"crossref","first-page":"4091","DOI":"10.1007\/s10792-021-01982-z","article-title":"An attempt to optimize the outcome of penetrating keratoplasty in congenital aniridia-associated keratopathy (AAK)","volume":"41","author":"Farah","year":"2021","journal-title":"Int Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.027_bib0023","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.ophtha.2017.07.009","article-title":"Visual outcomes and complications of type i boston keratoprosthesis in children: a retrospective multicenter study and literature review","volume":"125","author":"Fung","year":"2018","journal-title":"Ophthalmology"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.027_bib0024","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1097\/00003226-199609000-00004","article-title":"Recurrent keratopathy after penetrating keratoplasty for aniridia","volume":"15","author":"Gomes","year":"1996","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.027_bib0025","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/j.ophtha.2010.12.032","article-title":"Longer-term vision outcomes and complications with the Boston type 1 keratoprosthesis at the University of CA, Davis","volume":"118","author":"Greiner","year":"2011","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.027_bib0026","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/aos.12198x","article-title":"Clinical results of 40 years of paediatric keratoplasty in a single university eye clinic","volume":"92","author":"Hovlykke","year":"2014","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.027_bib0027","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/s12886-022-02460-5","article-title":"Clinical outcomes and visual prognostic factors in congenital aniridia","volume":"22","author":"Jacobson","year":"2022","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2025.11.027_bib0028","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S0002-9394(14)73581-0","article-title":"Results of penetrating keratoplasty in aniridia","volume":"115","author":"Kremer","year":"1993","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2025.11.027_bib0029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ajo.2017.10.017","article-title":"Corneal abnormalities in congenital aniridia: congenital central corneal opacity versus aniridia-associated keratopathy","volume":"185","author":"Lee","year":"2018","journal-title":"Am J Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajo.2025.11.027_bib0030","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/aos.13040","article-title":"Indications and outcomes of keratoplasties in children during a 40-year period","volume":"94","author":"Majander","year":"2016","journal-title":"Acta Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajo.2025.11.027_bib0031","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S1542-0124(12)70130-1","article-title":"Keratopathy in congenital aniridia","volume":"1","author":"Mayer","year":"2003","journal-title":"Ocul Surf"},{"key":"10.1016\/j.ajo.2025.11.027_bib0032","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.ajo.2019.06.018","article-title":"Glaucoma management in patients with aniridia and boston type 1 keratoprosthesis","volume":"207","author":"Nascimento e Silva","year":"2019","journal-title":"Am J Ophthalmol"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.027_bib0033","doi-asserted-by":"crossref","first-page":"291","DOI":"10.3341\/kjo.2010.24.5.291","article-title":"Clinical features of korean patients with congenital aniridia","volume":"24","author":"Park","year":"2010","journal-title":"Korean J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.027_bib0034","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1097\/ICO.0b013e318281724a","article-title":"Treatment of aniridia with boston type i keratoprosthesis","volume":"32","author":"Rixen","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/j.ajo.2025.11.027_bib0035","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ajo.2015.10.023","article-title":"Visual acuity outcomes of the Boston keratoprosthesis type 1: multicenter study results","volume":"162","author":"Rudnisky","year":"2016","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2025.11.027_bib0036","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/jcm13040975","article-title":"Outcomes of Boston keratoprosthesis type I implantation in poland: a retrospective study on 118 patients","volume":"13","author":"Wr\u00f3blewska-Czajka","year":"2024","journal-title":"J Clin Med"},{"key":"10.1016\/j.ajo.2025.11.027_bib0037","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ajo.2019.11.003","article-title":"Management of congenital aniridia-associated keratopathy: long-term outcomes from a tertiary referral center","volume":"210","author":"Yazdanpanah","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2025.11.027_bib0038","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/bjophthalmol-2020-317606","article-title":"Long-term outcomes following primary versus secondary Boston keratoprosthesis type 1 implantation","volume":"106","author":"Nayman","year":"2022","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2025.11.027_bib0039","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ophtha.2015.09.028","article-title":"Boston type 1 keratoprosthesis versus repeat donor keratoplasty for corneal graft failure: a systematic review and meta-analysis","volume":"123","author":"Ahmad","year":"2016","journal-title":"Ophthalmology"},{"issue":"11","key":"10.1016\/j.ajo.2025.11.027_bib0040","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1097\/ICO.0000000000002098","article-title":"Systematic review and meta-analysis of the medium- and long-term outcomes of the Boston type 1 keratoprosthesis","volume":"38","author":"Priddy","year":"2019","journal-title":"Cornea"},{"issue":"8","key":"10.1016\/j.ajo.2025.11.027_bib0041","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1038\/s41591-021-01458-8","article-title":"Accelerating the translational medicine cycle: the academia europaea pilot","volume":"27","author":"Hegyi","year":"2021","journal-title":"Nat Med"},{"issue":"5","key":"10.1016\/j.ajo.2025.11.027_bib0042","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3390\/jcm9051532","article-title":"Academia Europaea Position Paper on Translational Medicine: The Cycle Model for Translating Scientific Results into Community Benefits","volume":"9","author":"Hegyi","year":"2020","journal-title":"J Clin Med"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939425006282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,2]],"date-time":"2026-07-02T21:00:28Z","timestamp":1783026028000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939425006282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"alternative-id":["S0002939425006282"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.027","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes of Penetrating Keratoplasty and Boston Type 1 Keratoprosthesis in Aniridia-Associated Keratopathy: A Systematic Review and Meta-Analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2025.11.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}